2014
The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients
Edelman EJ, Chantarat T, Caffrey S, Chaudhry A, O’Connor P, Weiss L, Fiellin DA, Fiellin LE. The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients. Drug And Alcohol Dependence 2014, 139: 79-85. PMID: 24726429, PMCID: PMC4029496, DOI: 10.1016/j.drugalcdep.2014.03.006.Peer-Reviewed Original ResearchConceptsBuprenorphine/naloxone treatmentOpioid-dependent patientsHIV risk behaviorsBuprenorphine/naloxoneNon-condom useNaloxone treatmentRisk behaviorsTreatment initiationViral loadHIV-1 RNA viral loadCocaine/amphetaminesTime-updated variablesRNA viral loadMajor risk factorOpioid-dependent populationsCochran-Armitage trend testSexual risk behaviorsOlder patientsHIV infectionOpioid dependenceRisk factorsHeroin useHIVPatientsTargeted interventions
2002
Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility study
Broadhead RS, Heckathorn DD, Altice FL, van Hulst Y, Carbone M, Friedland GH, O’Connor P, Selwyn PA. Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility study. Social Science & Medicine 2002, 55: 235-246. PMID: 12144138, DOI: 10.1016/s0277-9536(01)00167-8.Peer-Reviewed Original ResearchConceptsActive drug usersDrug users' adherenceDrug usersDrug treatmentMedical carePrimary careIntervention feasibility studySocial support structuresHealth advocatesUser adherenceTreatment program staffPeer-driven interventionHIV diseaseHIV infectionPatient adherenceSix-month studyHIV treatmentPhysician referralClinical appointmentsHIV therapeuticsCarePositive behavioral changesAdherencePeer pressureTreatment
1997
PHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSE
Warner E, Kosten T, O'Connor P. PHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSE. Medical Clinics Of North America 1997, 81: 909-925. PMID: 9222260, DOI: 10.1016/s0025-7125(05)70555-1.Peer-Reviewed Original Research
1996
The substance-using human immunodeficiency virus patient: Approaches to outpatient management
O'Connor P, Samet J. The substance-using human immunodeficiency virus patient: Approaches to outpatient management. The American Journal Of Medicine 1996, 101: 435-444. PMID: 8873515, DOI: 10.1016/s0002-9343(96)00200-8.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusPrimary careHuman immunodeficiency virus (HIV) patientsAbuse treatmentPrimary care physiciansEffective primary careMaintenance of abstinenceSubstance use disordersLong-term abstinenceSubstance abuse treatmentSubstance abuse programsDrug abuse treatmentOutpatient managementVirus patientsHIV infectionWithdrawal syndromeCare physiciansMedical managementImmunodeficiency virusSubstance use historiesCommon complaintDrug treatmentUse disordersDrug useSpecific drugsSubstance Abuse and HIV/AIDS in Poland: Opportunities for Educational Exchange1
O'Connor P, Williams A. Substance Abuse and HIV/AIDS in Poland: Opportunities for Educational Exchange1. Substance Use & Addiction Journal 1996, 17: 101-109. DOI: 10.1080/08897079609444734.Peer-Reviewed Original ResearchInjection drug usersMethadone maintenance treatmentEpidemic of HIVSubstance abuse treatment systemLong-term residential treatmentEffective substance abuse treatmentClinical treatment approachesHIV/AIDSSubstance abuse treatmentHIV infectionMaintenance treatmentClean needlesHIV riskTreatment approachesDrug usersMedical careCocaine useMedical UniversityAbuse treatmentSubstance abuseResidential treatmentCareTreatmentAddiction problemsOpioids
1994
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users
Meandzija B, O'Connor P, Fitzgerald B, Rounsaville B, Kosten T. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug And Alcohol Dependence 1994, 36: 109-113. PMID: 7851277, DOI: 10.1016/0376-8716(94)90092-2.Peer-Reviewed Original ResearchConceptsIntravenous drug usersMethadone maintenance treatmentMethadone maintenance programHIV infectionCocaine useMore cocaine useMaintenance treatmentRisk factorsDrug usersMethadone maintenance treatment groupHuman immunodeficiency virus (HIV) transmissionAfrican AmericansMaintenance treatment groupNon-infected subjectsInjection frequencyHIV-negativeHIV testingDrug injectionStratified analysisTreatment groupsTotal cocaineHIVRisk behaviorsGreater riskInfection
1992
Human immunodeficiency virus infection in intravenous drug users: A model for primary care
O'Connor P, Molde S, Henry S, Shockcor W, Schottenfeld R. Human immunodeficiency virus infection in intravenous drug users: A model for primary care. The American Journal Of Medicine 1992, 93: 382-386. PMID: 1415300, DOI: 10.1016/0002-9343(92)90166-9.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPrimary careTuberculosis prophylaxisSyphilis treatmentVirus infectionDrug treatmentDrug usersPneumocystis carinii pneumonia prophylaxisHepatitis B vaccinePrimary care clinicsPrimary care servicesT-cell testingEligible patientsPneumonia prophylaxisAntiretroviral therapyB vaccineChart reviewPneumococcal vaccineT helperHIV infectionInfluenza vaccineCare clinicsMethadone maintenanceDIAGNOSIS AND TREATMENT OF SUBSTANCE USERS WITH HIV INFECTION
Selwyn P, O'Connor P. DIAGNOSIS AND TREATMENT OF SUBSTANCE USERS WITH HIV INFECTION. Primary Care Clinics In Office Practice 1992, 19: 119-156. PMID: 1594693, DOI: 10.1016/s0095-4543(21)00124-x.Peer-Reviewed Original ResearchConceptsHIV infectionDrug usersDrug-using patientsPrimary care cliniciansFavorable patient outcomesPrimary care providersPrimary care practitionersImportant clinical challengeSubstance use disordersDrug use problemsTreatment of substanceSubstance abuse problemsMedical complicationsPain managementCare cliniciansPatient outcomesComprehensive careDrug interactionsProvider awarenessClinical challengeDrug treatmentCare providersCare practitionersDrug useClinical staff